• Skip to primary navigation
  • Skip to main content
  • Skip to footer
United Health Products Inc Logo

United Health Products, Inc.

Innovative health products for the management of complicated bleeds.

  • Home
  • About
    • Leadership
    • Code of Ethics
  • Products
  • Careers
  • Investors
  • News
    • Press Releases
  • Contact

News

United Health Products Provides Regulatory and Business Update

April 27, 2022

Henderson, Nevada – April 27, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on its FDA regulatory process and other matters.   Regulatory Review As previously disclosed in the company’s Form 10-K, the U.S. Food & Drug Administration (FDA) requested in late January 2022 that i) the responses submitted by UHP […]

Filed Under: Press Releases

United Health Products Provides Regulatory and Business Update

April 1, 2022

Henderson, Nevada – April 1, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on its regulatory process, business condition, and other matters.   Regulatory Approvals Following the submission in October, 2021 of a response to the FDA’s questions and comments on its Premarket Approval (PMA) application, UHP and the FDA held […]

Filed Under: Press Releases

United Health Products Provides Regulatory Status Update

December 22, 2021

Henderson, Nevada – December 22, 2021 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the status of its application to the Food & Drug Administration (FDA) for Pre-market Approval (PMA) of its HemoStyp™ hemostatic gauze. On December 21st, the FDA informed UHP that its review of the PMA application is ongoing […]

Filed Under: Press Releases

United Health Products Provides Regulatory Update

October 27, 2021

Henderson, Nevada – October 27, 2021 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today confirmed it has submitted its response to the Food & Drug Administration’s (FDA) most recent questions and comments on the company’s Pre-market Approval (PMA) application. At this time there are no outstanding FDA information requests to UHP, however the FDA reserves […]

Filed Under: Press Releases

United Health Products Provides Business Update

October 7, 2021

Henderson, Nevada – October 7, 2021 – United Health Products, Inc. (OTCPK: UEEC), (UHP), developer, manufacturer and marketer of HemoStyp™, a patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic agent, today provided an update on its regulatory approval application process and other business activities. As part of its substantive review process to evaluate UHP’s PMA (Pre-market […]

Filed Under: Press Releases

United Health Products Provides Corporate Update and Announces Equity Financing

June 28, 2021

Initiation of laparoscopic study to expand potential Class III indications for HemoStyp® gauze Latest animal study demonstrates proof of concept and comparative performance of HemoStyp Gel format Discussions underway for clinical study to evaluate HemoStyp adhesive bandage benefits in hemodialysis applications $4,000,000 common stock purchase commitment to fund ongoing regulatory and product development priorities  Henderson, […]

Filed Under: Press Releases

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Go to Next Page »

Footer

Our Locations

Corporate Headquarters
520 Fellowship Road, Suite #D-406
Mt. Laurel, NJ 08054

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy

Contact Us

General Contact
info@uhpcorp.com
475.755.1005

Follow Us

  • Email
  • YouTube
  • Legal
  • Privacy Policy

Copyright © 2025 · United Health Products, Inc. All Rights Reserved. Website by Cindy Leigh Media